参芪平喘颗粒治疗慢性阻塞性肺病缓解期疗效观察  

Efficacy of Shenqi Pingchuan Granules in Treatment of Chronic Obstructive Pulmonary Disease in Remission Stage

作　　者：王士汉[1] 许有志[1] 郭红兵[1] 孙琮[1] 张阳阳[1] 

机构地区：[1]安徽省六安市中医院肺病科,安徽六安237006

出　　处：《安徽中医药大学学报》2014年第4期30-32,共3页Journal of Anhui University of Chinese Medicine

摘　　要：目的观察参芪平喘颗粒治疗慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)缓解期的疗效。方法共纳入41例缓解期COPD患者,在解痉平喘治疗的基础上,加服参芪平喘颗粒,3个月为1个疗程,共治疗3个疗程。观察治疗前后肺功能严重程度分级、ABCD分级、6min步行距离的变化。结果治疗9个月后,COPD患者肺功能严重程度分级和ABCD分级均无显著变化;肺功能Ⅲ级、Ⅳ级患者治疗后6min步行距离较治疗前显著提高(P<0.05)。结论参芪平喘颗粒能够提高缓解期COPD患者的生活质量,ABCD分级系统较肺功能严重程度分级更适合COPD患者病情的评估。Objective To investigate the efficacy of Shenqi Pingchuan Granules in the treatment of chronic obstructive pulmonary disease （COPD） in remission stage. Methods Forty-one patients with COPD in re mission stage were recruited in this study. Shenqi Pingchuan Granules were given in addition to spasmolytic and antiasthmatic treatment. Patients received three courses of treatment, each Iasting 3 months. The pulmonary function classification, ABCD classification, and 6-minute walk distance were assessed before and after treatment. Results No significant change was found in pulmonary function classification or ABCD classification after 9 months of treatment. Patients with pulmonary function classes Ⅲ and Ⅳ showed a significant increase in 6-minute walk distance after treatment （P〈0.05）. Conclusion Shenqi Pingchuan Granules improve the quality of life among patients with COPD in remission stage. ABCD classification is more suitable for assessment of COPD patient＇s condition than pulmonary function classification.

关 键 词：慢性阻塞性肺疾病 缓解期 参芪平喘颗粒 肺功能 ABCD分级系统 

分 类 号：R563[医药卫生—呼吸系统]